NNC0537-1482

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NNC0537-1482, covering 2025-06-25 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure [Phase 1]